Nature

Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study

We evaluated occupational exposure to endocrine disrupting chemicals (EDCs) among 2457 controls and 2178 incident lymphoma cases and subtypes from the European Epilymph study. Numerous synthetic ...
Nature

Organoids in endocrine and metabolic research: current and emerging applications

Organoid technologies are a potent tool for investigating human biology, modelling diseases and developing novel therapies. In this Viewpoint, experts in metabolic and endocrine research in the brain, ...

Endocrine-disrupting chemicals found in breast milk, new study reveals

A recent study revealed endocrine-disrupting chemicals (EDCs) in breast milk and infant urine, posing risks to newborns. Researchers found common chemicals like BPA and phthalates, linked to diet and ...
Medical Xpress

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a neurokinin-targeted therapy, reduces the ...
ascopubs.org

Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive ...

Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma A total of 501 patients were included in the analysis: 287 received ...
EurekAlert!

Study: Macrophage “bodyguard” disruptors could change breast cancer treatment by helping to overcome endocrine resistance

“This triple therapy approach could be a game-changer for patients whose (breast) cancers no longer respond to standard hormone treatments,” said Rumela Chakrabarti, Ph.D., the study’s senior author ...